Insulet Corporation (PODD)
Cash ratio
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 953,400 | 704,200 | 674,700 | 791,600 | 947,600 |
Short-term investments | US$ in thousands | — | 26,900 | 50,800 | 0 | 40,400 |
Total current liabilities | US$ in thousands | 528,400 | 451,200 | 364,700 | 228,800 | 207,800 |
Cash ratio | 1.80 | 1.62 | 1.99 | 3.46 | 4.75 |
December 31, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($953,400K
+ $—K)
÷ $528,400K
= 1.80
The cash ratio of Insulet Corporation has shown a declining trend over the past five years, decreasing from 4.75 in December 31, 2020, to 1.80 in December 31, 2024. This indicates that the company's ability to cover its short-term liabilities solely with cash and cash equivalents has weakened over this period. A cash ratio above 1.0 is generally considered healthy, as it shows the company has enough cash to cover its short-term obligations. However, the downward trajectory of Insulet's cash ratio may raise concerns about its liquidity position and ability to meet its immediate financial commitments solely from its available cash resources. Further analysis of the company's cash management and liquidity strategies may be warranted to address this trend.
Peer comparison
Dec 31, 2024